IRIS Accounts Production v24.2.0.383 03798705 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh037987052023-04-30037987052024-04-30037987052023-05-012024-04-30037987052022-04-30037987052022-05-012023-04-30037987052023-04-3003798705ns15:EnglandWales2023-05-012024-04-3003798705ns14:PoundSterling2023-05-012024-04-3003798705ns10:Director12023-05-012024-04-3003798705ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3003798705ns10:SmallEntities2023-05-012024-04-3003798705ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3003798705ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3003798705ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3003798705ns10:FullAccounts2023-05-012024-04-300379870512023-05-012024-04-3003798705ns10:Director22023-05-012024-04-3003798705ns10:RegisteredOffice2023-05-012024-04-3003798705ns5:CurrentFinancialInstruments2024-04-3003798705ns5:CurrentFinancialInstruments2023-04-3003798705ns5:Non-currentFinancialInstruments2024-04-3003798705ns5:Non-currentFinancialInstruments2023-04-3003798705ns5:ShareCapital2024-04-3003798705ns5:ShareCapital2023-04-3003798705ns5:RetainedEarningsAccumulatedLosses2024-04-3003798705ns5:RetainedEarningsAccumulatedLosses2023-04-3003798705ns5:PlantMachinery2023-05-012024-04-3003798705ns5:IntangibleAssetsOtherThanGoodwill2023-04-3003798705ns5:IntangibleAssetsOtherThanGoodwill2024-04-3003798705ns5:IntangibleAssetsOtherThanGoodwill2023-04-3003798705ns5:PlantMachinery2023-04-3003798705ns5:PlantMachinery2024-04-3003798705ns5:PlantMachinery2023-04-3003798705ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3003798705ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-30
REGISTERED NUMBER: 03798705 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

Pharma Pharma Ltd

Pharma Pharma Ltd (Registered number: 03798705)






Contents of the Financial Statements
for the year ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Pharma Pharma Ltd

Company Information
for the year ended 30 April 2024







DIRECTORS: N Siabi
Mrs T Siabi





REGISTERED OFFICE: 10 Nelmes Road
Hornchurch
Essex
RM11 3JA





REGISTERED NUMBER: 03798705 (England and Wales)





ACCOUNTANTS: S C Devlin Accountancy Ltd
Chartered Certified Accountants
3 Marlborough Close
Benfleet
Essex
SS7 4JA

Pharma Pharma Ltd (Registered number: 03798705)

Balance Sheet
30 April 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 4,751 4,751
Tangible assets 5 56,955 10,737
61,706 15,488

CURRENT ASSETS
Stocks 600 4,500
Debtors 6 263,007 210,644
Cash at bank 18,244 2,612
281,851 217,756
CREDITORS
Amounts falling due within one year 7 99,964 22,717
NET CURRENT ASSETS 181,887 195,039
TOTAL ASSETS LESS CURRENT
LIABILITIES

243,593

210,527

CREDITORS
Amounts falling due after more than one
year

8

(2,759

)

(5,359

)

PROVISIONS FOR LIABILITIES - (2,040 )
NET ASSETS 240,834 203,128

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 240,734 203,028
SHAREHOLDERS' FUNDS 240,834 203,128

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharma Pharma Ltd (Registered number: 03798705)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 October 2024 and were signed on its behalf by:





N Siabi - Director


Pharma Pharma Ltd (Registered number: 03798705)

Notes to the Financial Statements
for the year ended 30 April 2024

1. STATUTORY INFORMATION

Pharma Pharma Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.
Turnover is recognised upon transfer of the goods to the customer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Pharma Pharma Ltd (Registered number: 03798705)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 May 2023
and 30 April 2024 4,751
NET BOOK VALUE
At 30 April 2024 4,751
At 30 April 2023 4,751

Intangibles represents the costs of patents and licences and are not being depreciated.

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 35,487
Additions 62,011
At 30 April 2024 97,498
DEPRECIATION
At 1 May 2023 24,750
Charge for year 15,793
At 30 April 2024 40,543
NET BOOK VALUE
At 30 April 2024 56,955
At 30 April 2023 10,737

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 32,498 9,977
Other debtors 230,509 200,667
263,007 210,644

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 2,600 2,600
Trade creditors 3,186 -
Taxation and social security 4,491 9,248
Other creditors 89,687 10,869
99,964 22,717

Pharma Pharma Ltd (Registered number: 03798705)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 2,759 5,359

9. RELATED PARTY DISCLOSURES

The company has extended its commercial loan provisions during the period to £228,034 (2023 - was £196,500) to a company with a common director and shareholder.
There are no fixed repayment terms and no interest is being charged.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is N Siabi.